EIF1 and hepatocellular carcinoma: eIF1 was found to be increased a series of disease risks, such as aneurysmal bone cyst (18), Parkinson’s disease (19), hepatocellular carcinoma (HCC) (20), breast cancer (21) and ductal adenocarcinoma (22).